Ultimately, we found that CD3 on CD39(+) resting Tregs combined with 7-hoca levels jointly reduce the risk of glioma(Mediated effect, ME = 0.0479; Mediated proportion, MP = − 14.6%) (Table 1). This evidence concerns the gene ENTPD1 and central nervous system cancer.